Mariana M Ramirez-Mejia
Overview
Explore the profile of Mariana M Ramirez-Mejia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morales-Galicia A, Ramirez-Mejia M, Ponciano-Rodriguez G, Mendez-Sanchez N
World J Hepatol
. 2025 Jan;
16(12):1365-1370.
PMID: 39744204
The intersection between metabolic-associated steatotic liver disease (MASLD) and chronic hepatitis B virus (HBV) infection is an emerging area of research with significant implications for public health and clinical practice....
2.
Ramirez-Mejia M, Castillo-Castaneda S, Pal S, Qi X, Mendez-Sanchez N
J Clin Transl Hepatol
. 2024 Nov;
12(11):939-948.
PMID: 39544246
Bilirubin, the primary breakdown product of hemoproteins, particularly hemoglobin, plays a key role in the diagnosis, prognosis, and monitoring of liver diseases. In acute liver diseases, such as acute liver...
3.
Ramirez-Mejia M, Qi X, Abenavoli L, Mendez-Sanchez N
Ann Hepatol
. 2024 Aug;
29(6):101535.
PMID: 39147131
Recent efforts to reclassify non-alcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) are intended to divert attention to the...
4.
Castillo-Castaneda S, Cordova-Gallardo J, Rivera-Espinosa L, Chavez-Pacheco J, Ramirez-Mejia M, Mendez-Sanchez N
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125751
Bilirubin plays a key role in early diagnosis, prognosis, and prevention of liver diseases. Unconjugated bilirubin (UCB) requires conversion to a water-soluble form through liver glucuronidation, producing monoglucuronide (BMG) or...
5.
Ramirez-Mejia M, Qi X, Abenavoli L, Barranco-Fragoso B, Barbalho S, Mendez-Sanchez N
Ann Hepatol
. 2024 Jun;
29(5):101526.
PMID: 38945478
No abstract available.
6.
Mendez-Sanchez N, Ramirez-Mejia M
Clin Gastroenterol Hepatol
. 2024 May;
23(2):377-378.
PMID: 38777171
No abstract available.
7.
Ramirez-Mejia M, Eslam M, Mendez-Sanchez N
J Hepatol
. 2024 Mar;
81(1):e22-e23.
PMID: 38484916
No abstract available.
8.
Medina-Julio D, Ramirez-Mejia M, Cordova-Gallardo J, Peniche-Luna E, Cantu-Brito C, Mendez-Sanchez N
Med Sci Monit
. 2024 Jan;
30:e943417.
PMID: 38282346
Metabolic dysfunction-associated fatty liver disease or metabolic dysfunction-associated steatotic liver disease (MAFLD/MASLD), is a common chronic liver condition affecting a substantial global population. Beyond its primary impact on liver function,...
9.
Pal S, Castillo-Castaneda S, Diaz-Orozco L, Ramirez-Mejia M, Dorantes-Heredia R, Alonso-Morales R, et al.
Genes (Basel)
. 2023 Oct;
14(10).
PMID: 37895284
Gallstone disease and metabolic dysfunction-associated fatty liver disease (MAFLD) share numerous common risk factors and progression determinants in that they both manifest as organ-specific consequences of metabolic dysfunction. Nevertheless, the...
10.
Ramirez-Mejia M, Qi X, Abenavoli L, Romero-Gomez M, Eslam M, Mendez-Sanchez N
Ann Hepatol
. 2023 Jul;
28(6):101138.
PMID: 37468095
Non-alcoholic fatty liver disease (NAFLD) represents a global public health burden. Despite the increase in its prevalence, the disease has not received sufficient attention compared to the associated diseases such...